SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,526,000 | +15.2% | 7,800 | 0.0% | 0.54% | +6.7% |
| Q2 2020 | $1,325,000 | +47.2% | 7,800 | 0.0% | 0.51% | +22.9% |
| Q1 2020 | $900,000 | +1.0% | 7,800 | 0.0% | 0.42% | +24.6% |
| Q4 2019 | $891,000 | +33.8% | 7,800 | 0.0% | 0.33% | +22.0% |
| Q3 2019 | $666,000 | +23.3% | 7,800 | 0.0% | 0.27% | +22.4% |
| Q2 2019 | $540,000 | -26.2% | 7,800 | -22.0% | 0.22% | -29.2% |
| Q1 2019 | $732,000 | +29.1% | 10,000 | 0.0% | 0.32% | +15.4% |
| Q4 2018 | $567,000 | -26.5% | 10,000 | 0.0% | 0.27% | -18.8% |
| Q3 2018 | $771,000 | +16.1% | 10,000 | 0.0% | 0.34% | +5.7% |
| Q2 2018 | $664,000 | +27.0% | 10,000 | 0.0% | 0.32% | +19.5% |
| Q1 2018 | $523,000 | -2.2% | 10,000 | 0.0% | 0.27% | +1.5% |
| Q4 2017 | $535,000 | -1.7% | 10,000 | 0.0% | 0.26% | -7.1% |
| Q3 2017 | $544,000 | – | 10,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |